XML 78 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings per Share ("EPS"):
 9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Earnings per Share ("EPS"):
Earnings per Share ("EPS"):
The following table reconciles the numerator and denominator used in the computation of earnings per share for the three and nine months ended September 30, 2015 and 2014 (shares in thousands):
 
For the Three Months Ended September 30,
 
For the Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
Numerator
 
 
 
 
 
 
 
Net income
$
36,314

 
$
38,744

 
$
78,727

 
$
76,373

Net income attributable to noncontrolling interests
(2,717
)
 
(2,830
)
 
(6,124
)
 
(6,552
)
Net income attributable to the Company
33,597

 
35,914

 
72,603

 
69,821

Allocation of earnings to participating securities
(147
)
 
(122
)
 
(442
)
 
(373
)
Numerator for basic and diluted earnings per share—net income attributable to common stockholders
$
33,450

 
$
35,792

 
$
72,161

 
$
69,448

Denominator
 
 
 
 
 
 
 
Denominator for basic earnings per share—weighted average number of common shares outstanding
158,517

 
140,916

 
158,452

 
140,859

Effect of dilutive securities:(1)
 
 
 
 
 
 
 
Share and unit-based compensation plans
117

 
144

 
151

 
116

Denominator for diluted earnings per share—weighted average number of common shares outstanding
158,634

 
141,060

 
158,603

 
140,975

Earnings per common share—net income attributable to common stockholders:
 
 
 
 
 
 
 
Basic
$
0.21

 
$
0.25

 
$
0.46

 
$
0.49

Diluted
$
0.21

 
$
0.25

 
$
0.45

 
$
0.49

 
 
 
(1)
Diluted EPS excludes 138,759 and 184,304 convertible preferred units for the three months ended September 30, 2015 and 2014, respectively, and 139,330 and 184,304 convertible preferred units for the nine months ended September 30, 2015 and 2014, respectively, as their impact was antidilutive.
Diluted EPS excludes 10,576,632 and 10,110,716 Operating Partnership units ("OP Units") for the three months ended September 30, 2015 and 2014, respectively, and 10,557,254 and 10,072,321 OP Units for the nine months ended September 30, 2015 and 2014, respectively, as their impact was antidilutive.